Evidence map›Paper›PMID 35172886›Full record

ArticleJournal of cheminformatics2022

Reproducible untargeted metabolomics workflow for exhaustive MS2 data acquisition of MS1 features.

Miao Yu, Georgia Dolios, Lauren Petrick

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Diversifying cheminformatics.Journal of cheminformatics · 2022
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Miao YuDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. miao.yu@mssm.edu.ORCID http://orcid.org/0000-0002-2804-6014
Georgia DoliosDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Lauren PetrickDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Funding

The Mount Sinai Transdisciplinary Center on Early Environmental ExposuresP30ES023515 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Robert O Wright · 2014 to 2026
$21.3M
Untargeted Analysis ResourceU2CES030859 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ARORA, MANISH · 2019 to 2025
$8.2M
Environmental chemical mixtures and metabolomics in autism spectrum disorderR01ES031117 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI PETRICK, LAUREN · 2020 to 2024
$3.3M
Discovery of early life causes of autism spectrum disorder through retrospective metabolomics and proteome analysis of teethR21ES030882 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ANDRA, SYAM S, PETRICK, LAUREN · 2019 to 2020
$466k
Fetal Origins of Testicular Cancer: A Metabolomics Study in NewbornsUH2CA248974 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI METAYER, CATHERINE, PETRICK, LAUREN · 2021 to 2022
$434k
NCI NIH HHS UH2 CA248974NCI NIH HHS UH2CA248974NIEHS NIH HHS P30 ES023515NIEHS NIH HHS P30ES023515NIEHS NIH HHS R01 ES031117NIEHS NIH HHS R01ES031117NIEHS NIH HHS R21 ES030882NIEHS NIH HHS R21ES030882NIEHS NIH HHS U2C ES030859NIEHS NIH HHS U2CES030859
6 · The paper itself

Abstract

Unknown features in untargeted metabolomics and non-targeted analysis (NTA) are identified using fragment ions from MS/MS spectra to predict the structures of the unknown compounds. The precursor ion selected for fragmentation is commonly performed using data dependent acquisition (DDA) strategies or following statistical analysis using targeted MS/MS approaches. However, the selected precursor ions from DDA only cover a biased subset of the peaks or features found in full scan data. In addition, different statistical analysis can select different precursor ions for MS/MS analysis, which make the post-hoc validation of ions selected following a secondary analysis impossible for precursor ions selected by the original statistical method. Here we propose an automated, exhaustive, statistical model-free workflow: paired mass distance-dependent analysis (PMDDA), for reproducible untargeted mass spectrometry MS2 fragment ion collection of unknown compounds found in MS1 full scan. Our workflow first removes redundant peaks from MS1 data and then exports a list of precursor ions for pseudo-targeted MS/MS analysis on independent peaks. This workflow provides comprehensive coverage of MS2 collection on unknown compounds found in full scan analysis using a "one peak for one compound" workflow without a priori redundant peak information. We compared pseudo-spectra formation and the number of MS2 spectra linked to MS1 data using the PMDDA workflow to that obtained using CAMERA and RAMclustR algorithms. More annotated compounds, molecular networks, and unique MS/MS spectra were found using PMDDA compared with CAMERA and RAMClustR. In addition, PMDDA can generate a preferred ion list for iterative DDA to enhance coverage of compounds when instruments support such functions. Finally, compounds with signals in both positive and negative modes can be identified by the PMDDA workflow, to further reduce redundancies. The whole workflow is fully reproducible as a docker image xcmsrocker with both the original data and the data processing template.

Indexed as

Data analysisHigh-resolution mass spectrometryMetabolomicsOpen scienceReproducible researchWorkflow

Identifiers

PMID35172886
PMCPMC8848943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.